BILL · 2013–14 SESSION

SB 5130: Eosinophilia disorders

Concerning insurance coverage of treatment of eosinophilia gastrointestinal associated disorders.

Summary

  • Beginning January 1, 2016, or upon the earliest update of the state's benchmark plan, health insurance contracts must include coverage for the formulas necessary for the treatment of EGID. The specialized formulas must be covered regardless of the delivery method.

From the Senate Bill Report (Orig.) (SB 5130), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 21, 2013
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Senator (D-46)
Introduced
January 21, 2013 in the Senate
Last action
January 13, 2014
Companion bill
HB 1216
Budget
Has a fiscal note

AN ACT Relating to eosinophilia gastrointestinal associated disorders;

Sponsors

Prime sponsor: Senator (D-46)

5 co-sponsors (5 Democrats, 0 Republicans)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. First reading, referred to Health Care.

SB 5130 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page